GABA(A) receptor occupancy by subtype selective GABA(Aα2,3) modulators: PET studies in humans

RATIONALE: Sedation, dependence, and abuse liability limit the use of non-selective γ-aminobutyric acid (GABA(A)) receptor positive modulators for the treatment of anxiety. AZD7325 and AZD6280 are novel, subtype-selective GABA(Aα2,3) receptor positive modulators with limited sedative effects. OBJECT...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Psychopharmacology (Berl)
Autores principales: Jucaite, Aurelija, Cselényi, Zsolt, Lappalainen, Jaakko, McCarthy, Dennis J., Lee, Chi-Ming, Nyberg, Svante, Varnäs, Katarina, Stenkrona, Per, Halldin, Christer, Cross, Alan, Farde, Lars
Formato: Artigo
Lenguaje:Inglês
Publicado: Springer Berlin Heidelberg 2016
Materias:
Original Investigation
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5263201/
https://ncbi.nlm.nih.gov/pubmed/28013354
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00213-016-4506-4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares